DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Foscavir (Foscarnet) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Foscavir (Foscarnet) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (37)
Death (20)
Life Threatening Events (12)
Disability (3)

Reports by Reaction Type

Renal Failure Acute (7)Multi-Organ Failure (6)Pancytopenia (6)Renal Impairment (6)Anaemia (5)Septic Shock (5)Toxic Epidermal Necrolysis (4)Encephalitis Cytomegalovirus (4)Cytomegalovirus Infection (4)Hepatic Function Abnormal (3)Pyrexia (3)Pneumonia Cytomegaloviral (3)

Below are a few examples of reports where side effects / adverse reactions may be related to Foscavir (Foscarnet). For a complete list or a specific selection of reports, please use the links above.

Possible Foscavir side effects in 64 year old female

Reported by a individual with unspecified qualification from United States on 2012-08-08

Patient: 64 year old female

Reactions: Retinal Detachment, Vitreous Haemorrhage, Visual Acuity Reduced, Retinal Ischaemia

Drug(s) suspected as cause:
Foscavir
    Dosage: -1.00 times per-3.0days ophthalmic
    Indication: Herpes Simplex

Valaciclovir
    Dosage: -3.00 times per-1.odays oral
    Administration route: Oral
    Indication: Herpes Simplex

Other drugs received by patient: Bactrim; Prednisone TAB



Possible Foscavir side effects in 51 year old male

Reported by a individual with unspecified qualification from Japan on 2012-08-08

Patient: 51 year old male

Reactions: Renal Impairment, Fungal Test Positive, Dialysis, Pulmonary Alveolar Haemorrhage, Genital Ulceration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Foscavir



Possible Foscavir side effects in 40 year old female

Reported by a individual with unspecified qualification from Italy on 2012-08-08

Patient: 40 year old female

Reactions: Multi-Organ Failure, Continuous Haemodiafiltration, Septic Shock, Renal Failure Acute

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Foscavir

Other drugs received by patient: Rapamune(rapamune); Myfortic(myfortic); Levofloxacina(levofloxacina); Fludarabine Phosphate; Vfend; Treosulfan(treosulfan); Mabthera; Bactrim; ATG-Fresenius(atg-Fresenius); Urbason(urbason)



Possible Foscavir side effects in female

Reported by a physician from Italy on 2012-08-07

Patient: female

Reactions: Death, Multi-Organ Failure, Septic Shock, Renal Failure Acute

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Foscavir

Other drugs received by patient: Levofloxacin; Mabthera; Vfend; Treosulfano; Anti-Thymocyte Globulin NOS; Rapamune; Methylprednisolone; Bactrim; Myfortic; Fludarabine Phosphate



Possible Foscavir side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-27

Patient: female

Reactions: Death, Multi-Organ Failure, Septic Shock, Renal Failure Acute

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Foscavir

Other drugs received by patient: Myfortic; Levofloxacin; Anti-Thymocyte Globulin NOS; Rapamune; Treosulfano; Fludarabine Phosphate; Mabthera; Methylprednisolone; Bactrim; Vfend



Possible Foscavir side effects in 27 year old female

Reported by a individual with unspecified qualification from France on 2012-07-17

Patient: 27 year old female

Reactions: Anaphylactic Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Foscavir
    Dosage: intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-10
    End date: 2012-02-10

Cancidas
    Dosage: 70.00 mg
    Indication: Candidiasis
    Start date: 2012-02-10
    End date: 2012-02-10

Other drugs received by patient: Gaviscon; Truvada; Lederfoline( Lederfoline); Raltegravir (Raltegravir); Inexium (Inexium); Fluconazole; Diffu K (Diffu K); Bactrim; Primperan (Primperan); Rovalcyte (Rovalcyte)



Possible Foscavir side effects in female

Reported by a physician from Japan on 2012-06-06

Patient: female, weighing 53.5 kg (117.7 pounds)

Reactions: Oligohydramnios, Renal Impairment, Maternal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Foscavir
    Indication: Cytomegalovirus Enterocolitis

Candesartan Cilexetil
    Dosage: 4 mg, uid/qd
    Administration route: Oral
    Indication: Renal Disorder
    Start date: 2010-01-04
    End date: 2010-12-16

Prograf
    Administration route: Oral
    Indication: Immunosuppressant Drug Therapy

Other drugs received by patient: Candesartan Cilexetil; Cotrim



Possible Foscavir side effects in 26 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-11

Patient: 26 year old female

Reactions: Hypersensitivity

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cancidas
    Start date: 2012-02-10
    End date: 2012-02-10

Foscavir
    Start date: 2012-02-10
    End date: 2012-02-10



Possible Foscavir side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-09

Patient: 55 year old male

Reactions: Confusional State, Sensory Loss, Muscular Weakness, Paraesthesia, Cytomegalovirus Myelomeningoradiculitis, Encephalitis Cytomegalovirus, Quadriparesis, Hyporeflexia, Urinary Retention

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Foscavir

Other drugs received by patient: Immunoglobulin G; Thiotepa; Fludarabine Phosphate; Antithymocyte-Globuline ATG / Rabbit Anti-Human Thymocyte Immunoglobulin; Immunoglobulin A / Immunoglobulins; Melphalan Hydrochloride



Possible Foscavir side effects in 25 year old male

Reported by a consumer/non-health professional from Japan on 2012-04-23

Patient: 25 year old male, weighing 57.0 kg (125.4 pounds)

Reactions: Eyelid Oedema, Pneumonia Viral, Gastrointestinal Haemorrhage, Hepatic Function Abnormal, Graft Versus Host Disease, Disseminated Intravascular Coagulation, Headache, Pyrexia, Oral Herpes, Pneumonia Cytomegaloviral, Generalised Oedema, Pericardial Effusion, Pneumocystis Jiroveci Pneumonia, Interstitial Lung Disease, Liver Function Test Abnormal, Pleural Effusion, Enterocolitis, Bronchopulmonary Aspergillosis, White Blood Cell Count Decreased, Anaemia, Pulmonary Haemorrhage, Renal Impairment, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Itraconazole
    Dosage: capsule;400-200mg/day(06jul-16jul09)inj.
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2009-06-06
    End date: 2009-07-16

Foscavir
    Dosage: form:inj1 df= 10 unit nos
    Start date: 2009-07-10
    End date: 2009-07-16

Bactrim
    Dosage: 1df=1tab;800mg/day(02jul-18jul09)inj.
    Administration route: Oral
    Indication: Antibiotic Prophylaxis
    Start date: 2009-04-14
    End date: 2009-07-16

Farom
    Administration route: Oral
    Start date: 2009-04-28
    End date: 2009-05-01

Neoral
    Dosage: 09jul-16jul09. 125mg/day sandimmun:inj:50mg/dy:09jul-16jul09
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2009-04-14
    End date: 2009-07-08

Sprycel
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-04-16
    End date: 2009-07-08

Maxipime
    Start date: 2009-04-24
    End date: 2009-04-27

Other drugs received by patient: Ceftazidime; Solu-Medrol; Ambisome; Piperacillin and Tazobactam; Pentamidine Isethionate; Ganciclovir; Meropenem; Omegacin; Sandimmune; Prednisolone



Possible Foscavir side effects in female

Reported by a individual with unspecified qualification from United Kingdom on 2012-04-10

Patient: female, weighing 20.0 kg (44.0 pounds)

Reactions: Hypertensive Encephalopathy, Electroencephalogram Abnormal, Posterior Reversible Encephalopathy Syndrome, Convulsion

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Foscavir
    Dosage: 2400, mg milligram(s), 1, 1, days intravenous (not otherwise specified)
    Start date: 2012-01-16
    End date: 2012-01-25

Cyclosporine
    Dosage: 1.45, mg/kg milligram(s)/kilogram intravenous (not otherwise specified)
    Indication: Prophylaxis Against Transplant Rejection
    Start date: 2011-12-15
    End date: 2012-01-24

Meropenem
    Dosage: 1200, mg milligram(s), 1, 1, days intravenous (not otherwise specified)

Targocid
    Dosage: 200, mg milligram(s), 1, 1, days intravenous (not otherwise specified)

Other drugs received by patient: Leflunomide: Oral / Leflunomide; Vfend: Intravenous (Not Otherwise Specified) / Voriconazole; Filgrastim: Intravenous (Not Otherwise Specified) / Filgrastim



Possible Foscavir side effects in female

Reported by a physician from France on 2012-03-09

Patient: female, weighing 20.0 kg (44.0 pounds)

Reactions: Posterior Reversible Encephalopathy Syndrome, Convulsion

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Meropenem
    Start date: 2012-01-13
    End date: 2012-01-21

Targocid
    Start date: 2012-01-13
    End date: 2012-01-21

Cyclosporine
    Indication: Prophylaxis Against Transplant Rejection
    Start date: 2011-12-15
    End date: 2012-01-24

Foscavir
    Start date: 2012-01-16
    End date: 2012-01-25

Other drugs received by patient: Filgrastim; Leflunomide; Vfend



Possible Foscavir side effects in 46 year old male

Reported by a individual with unspecified qualification from France on 2012-03-09

Patient: 46 year old male

Reactions: Renal Tubular Disorder, Renal Impairment, Scrotal Ulcer, Proteinuria, Haematuria, Toxicity To Various Agents, Chemical Injury

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Foscavir

Other drugs received by patient: Orbenine / Cloxacillin Sodium Monohydrate; Aransep / Darbepoetin Alfa; Calcidia / Calcium Carbonate



Possible Foscavir side effects in 9 year old female

Reported by a physician from Japan on 2012-03-07

Patient: 9 year old female

Reactions: Ventricular Extrasystoles, Blood Bilirubin Increased, Weight Increased, Haemoglobin Decreased, Renal Failure, Respiratory Failure, Dialysis, Blood Potassium Decreased, Pulmonary Congestion, Pleural Effusion, Platelet Count Decreased, Neuroblastoma Recurrent, Pulmonary Oedema, Cardiac Arrest

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Foscavir
    Dosage: parenteral
    Indication: Cytomegalovirus Infection
    Start date: 2008-04-15
    End date: 2008-04-22

Targpocid (Teicoplanin)
    Dosage: parenteral
    Indication: Infection
    Start date: 2008-04-20
    End date: 2008-04-25

Prograf
    Dosage: 0.1 mg, unknown/d, parenteral
    Indication: Graft Versus Host Disease
    End date: 2008-04-27

Ambisome
    Dosage: 49.2 mg, uid/qd, parenteral; 50 mg, uid/qd, parenteral
    Indication: Pyelonephritis Fungal
    Start date: 2008-04-23
    End date: 2008-04-25

Ambisome
    Dosage: 49.2 mg, uid/qd, parenteral; 50 mg, uid/qd, parenteral
    Indication: Pyelonephritis Fungal
    Start date: 2008-04-09
    End date: 2008-04-22

Neutrogin (Lenograstim)
    Dosage: 100 ug, uid/qd, iv nos; dr, parenteral
    Indication: Neutropenia
    Start date: 2008-04-15
    End date: 2008-04-26

Neutrogin (Lenograstim)
    Dosage: 100 ug, uid/qd, iv nos; dr, parenteral
    Indication: Neutropenia
    Start date: 2008-04-27
    End date: 2008-04-30

Anitvirals FOR Systemic USE (Antivirals FOR Systemic Use)
    Dosage: iv nos; iv nos; iv nos
    Indication: Viral Infection
    Start date: 2008-05-06
    End date: 2008-05-06

Anitvirals FOR Systemic USE (Antivirals FOR Systemic Use)
    Dosage: iv nos; iv nos; iv nos
    Indication: Viral Infection
    Start date: 2008-04-23
    End date: 2008-04-23

Anitvirals FOR Systemic USE (Antivirals FOR Systemic Use)
    Dosage: iv nos; iv nos; iv nos
    Indication: Viral Infection
    Start date: 2008-05-10
    End date: 2008-05-10

Other drugs received by patient: Vfend; Solu-Medrol; Nicardipine Hydrochloride; Sodium Chloride 0.9%; Atraxa-P (Hydroxyzine Hydrochloride); Capillary Stablizing Agents; Amoban (Zopiclone); Elemenmic (Minerals Nos); Potassium Chloride; Omepral (Omperazole); Morphine Hydrochloride (Morphine Hydrochloride); Urso (Ursodexoycholic Acid); Dopamine Hydrochloride; Firstcin (Cefozopran Hydrochloride); Fulcaliq 2; Novo Heparin Calcium (Heparin Calcium); Sulfamethoxazole and Trimethoprim; Alprostadil; Albumin (Human)



Possible Foscavir side effects in female

Reported by a physician from Japan on 2012-03-07

Patient: female, weighing 53.5 kg (117.7 pounds)

Reactions: Oligohydramnios, Renal Impairment, Maternal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prograf
    Administration route: Oral
    Indication: Immunosuppressant Drug Therapy

Foscavir
    Indication: Cytomegalovirus Enterocolitis

Candesartan Cilexetil
    Dosage: 4 mg, uid/qd
    Administration route: Oral
    Indication: Renal Disorder
    Start date: 2010-01-04
    End date: 2010-12-16

Other drugs received by patient: Cotrim; Candesartan Cilexetil



Possible Foscavir side effects in female

Reported by a physician from Japan on 2012-03-05

Patient: female, weighing 53.5 kg (117.7 pounds)

Reactions: Renal Impairment, Maternal Exposure During Pregnancy, Polyhydramnios

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Foscavir
    Indication: Cytomegalovirus Enterocolitis

Prograf
    Administration route: Oral
    Indication: Immunosuppressant Drug Therapy

Candesartan Cilexetil
    Dosage: 4 mg, uid/qd
    Administration route: Oral
    Indication: Renal Disorder
    Start date: 2010-01-04
    End date: 2010-12-16

Other drugs received by patient: Cotrim; Candesartan Cilexetil



Possible Foscavir side effects in 46 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-28

Patient: 46 year old male

Reactions: Renal Tubular Disorder, Scrotal Ulcer

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Foscavir

Other drugs received by patient: Calcidia; Orbenin CAP; Aranesp



Possible Foscavir side effects in 28 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-24

Patient: 28 year old female

Reactions: Encephalitis Cytomegalovirus, Renal Failure, Oliguria, Oedema Peripheral, Cytomegalovirus Viraemia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mycophenolate Mofetil
    Dosage: 2000 mg/day from day 1 before second cbt
    Administration route: Oral
    Indication: Prophylaxis Against Graft Versus Host Disease

Foscavir
    Start date: 2011-06-03

Anti-Thymocyte Globulin NOS
    Dosage: 2.5 mg/kg starting on day -4 during third cbt

Fludarabine Phosphate
    Dosage: 25 mg/m2 starting on day -7 during second cbt

Foscavir
    Start date: 2011-04-20

Cyclophosphamide
    Dosage: 60 mg/kg on day-7 and -6 during third cbt

Cyclosporine
    Dosage: 3 mg/kg/day starting from day 1 before the third cbt
    Indication: Prophylaxis Against Graft Versus Host Disease

Foscavir
    Indication: Encephalitis Cytomegalovirus

Busulfan
    Dosage: 4 mg/kg starting on day -7 during second cbt

Methotrexate
    Dosage: 2000 mg/day from day 1 before second cbt
    Indication: Prophylaxis Against Graft Versus Host Disease

Methylprednisolone
    Dosage: 80 mg/day on day -3 during third cbt

TBI / TLI
    Dosage: 7.25 gy, day -1 during third cbt

Tacrolimus
    Dosage: 0.2 mg/kg/day from day 1 before second cbt
    Indication: Prophylaxis Against Graft Versus Host Disease

Cyclophosphamide
    Dosage: 50 mg/kg on day-3 and -2 during first cbt

TBI / TLI
    Dosage: 12 gy/6 fractions on day -7. -6 and -4 during first cbt

Methylprednisolone
    Dosage: 40 mg/day on day -4 during third cbt



Possible Foscavir side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-24

Patient: 69 year old female

Reactions: Jaundice, Respiratory Disorder, Renal Disorder, Anaemia, Stenotrophomonas Infection, Lactic Acidosis, Pyrexia, Liver Disorder, Epstein-Barr Virus Infection, Multi-Organ Failure, Hepatomegaly, Cytomegalovirus Infection, Diffuse Large B-Cell Lymphoma, Lymphangiopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Anti-Thymocyte Globulin Equine NOS
    Dosage: 3.5 mg/kg for five days
    Indication: Aplastic Anaemia
    Start date: 2010-09-15

Foscavir
    Dosage: unk ukn, unk

Neoral
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Aplastic Anaemia
    Start date: 2010-05-01

Other drugs received by patient: Neupogen; Blood and Related Products; Primobolan-Depot INJ



Possible Foscavir side effects in 28 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-23

Patient: 28 year old female

Reactions: Encephalitis Cytomegalovirus, Pathogen Resistance

Adverse event resulted in: death

Drug(s) suspected as cause:
Foscavir
    Dosage: ssee image
    Indication: Encephalitis Cytomegalovirus
    Start date: 2011-04-20

Foscavir
    Dosage: ssee image
    Indication: Encephalitis Cytomegalovirus
    Start date: 2011-03-06

Foscavir
    Dosage: 90, mg/kg milligram(s)/kilogram, 1, 12, hours
    Indication: Encephalitis Cytomegalovirus
    Start date: 2011-03-06

Ganciclovir
    Dosage: see image
    Indication: Encephalitis Cytomegalovirus
    Start date: 2011-03-06

Ganciclovir
    Dosage: see image
    Indication: Encephalitis Cytomegalovirus
    Start date: 2011-05-18

Ganciclovir
    Dosage: 2.5, mg/kg milligram(s)/kilogram, 1, 12, hours
    Start date: 2011-03-06



Possible Foscavir side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-21

Patient: 69 year old female

Reactions: Jaundice, Respiratory Disorder, Renal Disorder, Anaemia, Stenotrophomonas Infection, Pyrexia, Lactic Acidosis, Liver Disorder, Multi-Organ Failure, Epstein-Barr Virus Infection, Hepatomegaly, Cytomegalovirus Infection, Diffuse Large B-Cell Lymphoma, Lymphangiopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Anti-Thymocyte Globulin Equine NOS
    Dosage: 3.5 mg/kg for five days
    Indication: Aplastic Anaemia
    Start date: 2010-09-15

Foscavir
    Dosage: unk ukn, unk

Neoral
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Aplastic Anaemia
    Start date: 2010-05-01

Other drugs received by patient: Primobolan-Depot INJ; Blood and Related Products; Neupogen



Possible Foscavir side effects in 28 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-17

Patient: 28 year old female

Reactions: Encephalitis Cytomegalovirus

Adverse event resulted in: death

Drug(s) suspected as cause:
Ganciclovir
    Start date: 2011-06-03

Ganciclovir
    Indication: Encephalitis Cytomegalovirus
    Start date: 2011-05-18

Foscavir
    Indication: Encephalitis Cytomegalovirus
    Start date: 2011-04-20

Foscavir
    Start date: 2011-06-03



Possible Foscavir side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-10

Patient: 55 year old male

Reactions: Bronchopulmonary Aspergillosis, Endocarditis Bacterial, Toxic Epidermal Necrolysis, Condition Aggravated, Cholestasis, Multi-Organ Failure, Cytomegalovirus Infection, Febrile Bone Marrow Aplasia, Bilirubin Conjugated Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Gentamicin
    Indication: Endocarditis
    Start date: 2004-12-22
    End date: 2005-01-14

Amoxicillin Trihydrate
    Dosage: 2 g, 6xday
    Administration route: Oral
    Indication: Endocarditis
    Start date: 2004-12-22
    End date: 2005-01-14

Foscavir
    Indication: Cytomegalovirus Infection
    Start date: 2004-12-30
    End date: 2005-01-14

Fungizone
    Indication: Aspergillosis
    Start date: 2005-01-04
    End date: 2005-01-14

Pantoprazole
    Dosage: 40 mg, 1x/day
    Administration route: Oral
    Indication: Oesophageal Ulcer
    Start date: 2004-12-14
    End date: 2005-01-14

Vfend
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2004-12-30
    End date: 2005-01-04

Cymevan
    Dosage: 160 mg, 1x/day
    Indication: Cytomegalovirus Infection
    Start date: 2004-12-14
    End date: 2005-01-14

Other drugs received by patient: Prednisone TAB; Pantoprazole; Bactrim



Possible Foscavir side effects in female

Reported by a physician from Finland on 2011-12-29

Patient: female

Reactions: Anaemia, Hepatic Enzyme Increased, Interstitial Lung Disease, Diarrhoea, Staphylococcal Infection, Aspergillosis, Cytomegalovirus Infection, Neutropenia, Blood Creatinine Increased, Sinusitis, Thrombocytopenia, Soft Tissue Neoplasm, Herpes Virus Infection, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Fludarabine Phosphate
    Indication: Chronic Lymphocytic Leukaemia

Alemtuzumab
    Indication: Chronic Lymphocytic Leukaemia

Mabthera
    Indication: Chronic Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Chronic Lymphocytic Leukaemia

Valcyte
    Administration route: Oral
    Indication: Cytomegalovirus Infection
    Start date: 2010-04-26

Foscavir
    Indication: Cytomegalovirus Infection

Other drugs received by patient: Cyclosporine; Fluconazole; Emgesan; Valtrex; Ratiograstim; Lansoprazole; Prednisone TAB; Neulasta; Ceftazidime; Ribavirin; Hydrocortisone; Gensumycin; Ditrim Duplo; Multitabs; Calcium Carbonate; Adursal; Avelox; Tenox; Ceftriaxone; Mycophenolate Mofetil (Cellcept); Vitamin C; Ceftazidime; Medrol; Pulmicort; Zithromax; Diflucan



Possible Foscavir side effects in 57 year old male

Reported by a physician from France on 2011-12-28

Patient: 57 year old male

Reactions: Toxic Epidermal Necrolysis

Adverse event resulted in: death

Drug(s) suspected as cause:
Rocephin
    Start date: 2011-06-10
    End date: 2011-06-11

Flagyl
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29
    End date: 2011-06-08

Solu-Medrol
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-30
    End date: 2011-06-08

Foscavir
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-01
    End date: 2011-06-12

Rocephin
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Nozinan (United Kingdom)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-30
    End date: 2011-06-10

Nexium
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-30
    End date: 2011-06-10

Other drugs received by patient: Acupan; Umuline



Possible Foscavir side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2011-12-27

Patient: 58 year old female

Reactions: Cytomegalovirus Colitis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Ganciclovir Sodium
    Indication: Cytomegalovirus Colitis

Foscavir
    Dosage: intravenous (not otherwise specified)



Possible Foscavir side effects in 24 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-20

Patient: 24 year old female

Reactions: Pancytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Amikacin
    Indication: Febrile Convulsion
    Start date: 2011-09-09
    End date: 2011-01-01

Foscavir
    Indication: Cytomegalovirus Infection
    Start date: 2011-09-03
    End date: 2011-09-09

Vancomycin HCL
    Indication: Febrile Convulsion
    Start date: 2011-09-09

Primaxin
    Indication: Febrile Convulsion
    Start date: 2011-09-09
    End date: 2011-09-18

Primaxin
    Start date: 2011-10-02

Ganciclovir Sodium
    Indication: Cytomegalovirus Infection
    Start date: 2011-08-30
    End date: 2011-09-16

Foscavir
    Start date: 2011-09-30

Other drugs received by patient: Piperacillin and Tazobactam; Cancidas; Imuran; Cancidas; Piperacillin and Tazobactam



Possible Foscavir side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-16

Patient: 56 year old male

Reactions: Hyperkalaemia, Anaemia, Disseminated Intravascular Coagulation, Toxic Epidermal Necrolysis, Pancytopenia, Haemodynamic Instability, Haemolysis, Cardio-Respiratory Arrest, Simplex Virus Test Positive, Ventricular Fibrillation, Escherichia Sepsis, Renal Failure Acute, Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Solu-Medrol
    Dosage: unk
    Start date: 2011-05-30
    End date: 2011-06-08

Nozinan
    Dosage: unk
    Start date: 2011-06-07
    End date: 2011-06-10

Nexium
    Dosage: unk
    Start date: 2011-05-30
    End date: 2011-06-10

Foscavir
    Dosage: unk
    Start date: 2011-06-01
    End date: 2011-06-11

Rocephin
    Dosage: unk
    Start date: 2011-05-29
    End date: 2011-06-08

Rocephin
    Dosage: unk
    Start date: 2011-06-10
    End date: 2011-06-11

Flagyl
    Dosage: unk
    Start date: 2011-05-29
    End date: 2011-06-08

Other drugs received by patient: Prednisone TAB; Acupan; Umuline



Possible Foscavir side effects in 57 year old male

Reported by a physician from France on 2011-12-16

Patient: 57 year old male

Reactions: Toxic Epidermal Necrolysis

Adverse event resulted in: death

Drug(s) suspected as cause:
Rocephin
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29
    End date: 2011-06-11

Solu-Medrol
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-30
    End date: 2011-06-08

Nozinan (United Kingdom)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-30
    End date: 2011-06-10

Rocephin
    Start date: 2011-06-10
    End date: 2011-06-11

Flagyl
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29
    End date: 2011-06-08

Nexium
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-30
    End date: 2011-06-10

Foscavir
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-01
    End date: 2011-06-11

Other drugs received by patient: Acupan; Umuline



Possible Foscavir side effects in 58 year old female

Reported by a physician from Czech Republic on 2011-12-08

Patient: 58 year old female, weighing 53.0 kg (116.6 pounds)

Reactions: Cytomegalovirus Colitis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Ganciclovir Sodium
    Indication: Cytomegalovirus Colitis

Foscavir

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014